blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3582798

EP3582798 - UNIVERSAL ANTIVENOM [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  02.06.2022
Database last updated on 14.06.2024
FormerRequest for examination was made
Status updated on  22.11.2019
FormerThe international publication has been made
Status updated on  25.08.2018
Most recent event   Tooltip22.05.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
DayLife LLC
2908 Flamingo Drive
Miami Beach, FL 33140 / US
[2024/18]
Former [2019/52]For all designated states
Camris International, Inc.
3 Bethesda Metro Center
Suite 1600
Bethesda, MD 20814 / US
Inventor(s)01 / HWANG, Yoon, Y.
3135 Highline Trl.
San Antonio, TX 78261 / US
 [2019/52]
Representative(s)Predazzi, Valentina, et al
Società Italiana Brevetti S.p.A.
Piazza di Pietra, 39
00186 Roma / IT
[2019/52]
Application number, filing date18753759.216.02.2018
[2019/52]
WO2018US00084
Priority number, dateUS201762460213P17.02.2017         Original published format: US 201762460213 P
[2019/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018151867
Date:23.08.2018
Language:EN
[2018/34]
Type: A1 Application with search report 
No.:EP3582798
Date:25.12.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 23.08.2018 takes the place of the publication of the European patent application.
[2019/52]
Search report(s)International search report - published on:US23.08.2018
(Supplementary) European search report - dispatched on:EP30.10.2020
ClassificationIPC:A61K38/08, A61K38/10, A61K38/12, A61K35/76, C07K7/06, C07K7/04, C07K7/64, C12N15/73
[2019/52]
CPC:
C07K7/06 (EP,KR); A61K38/08 (EP,KR,US); C07K7/64 (US);
A61K38/10 (EP,KR); A61P39/02 (EP,KR); C07K7/08 (EP,KR);
C12N15/73 (US); A61K38/00 (US); C12N2795/14121 (EP,KR,US);
C12N2795/14131 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/52]
TitleGerman:UNIVERSELLES GEGENGIFT[2019/52]
English:UNIVERSAL ANTIVENOM[2019/52]
French:ANTIVENIN UNIVERSEL[2019/52]
Entry into regional phase19.08.2019National basic fee paid 
19.08.2019Search fee paid 
19.08.2019Designation fee(s) paid 
19.08.2019Examination fee paid 
Examination procedure19.08.2019Examination requested  [2019/52]
18.06.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
29.07.2021Amendment by applicant (claims and/or description)
01.06.2022Despatch of a communication from the examining division (Time limit: M06)
06.12.2022Reply to a communication from the examining division
21.05.2024Despatch of a communication from the examining division (Time limit: M04)
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
29.07.2021Request for further processing filed
29.07.2021Full payment received (date of receipt of payment)
Request granted
06.08.2021Decision despatched
Fees paidRenewal fee
10.09.2019Renewal fee patent year 03
23.02.2021Renewal fee patent year 04
09.02.2022Renewal fee patent year 05
09.02.2023Renewal fee patent year 06
13.02.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]  - Alexandra Rucavado ET AL, "Effect of the metalloproteinase inhibitor batimastat in the systemic toxicity induced by Bothrops asper snake venom: understanding the role of metalloproteinases in envenomation", Toxicon, VOL. 43, N.4, (20040301), pages 417 - 424, URL: https://ac.els-cdn.com/S0041010104000480/1-s2.0-S0041010104000480-main.pdf?_tid=5e4b1634-04fa-11e8-86d8-00000aab0f26&acdnat=1517233581_acf42aa113b182bfe18307357937c59b, (20180129), XP055445653 [A] 1-23 * the whole document *
 [A]  - CLARK J D ET AL, "Potential therapeutic uses of phospholipase A2 inhibitors", EXPERT OPINION ON THERAPEUTIC PATENTS, TAYLOR & FRANCIS, GB, (20040101), vol. 14, no. 7, doi:10.1517/13543776.14.7.937, ISSN 1354-3776, pages 937 - 950, XP002405708 [A] 1-23 * the whole document *

DOI:   http://dx.doi.org/10.1517/13543776.14.7.937
 [A]  - BALASS M ET AL, "Mode of inhibition of phospholipase A2 activity of beta-bungarotoxin by a characteristic library-derived peptide", NEURAL PLASTICITY, HINDAWI PUBLISHING, US, vol. 10, no. 3, ISSN 1687-5443, (20031216), pages 181 - 182, (20031216), XP008101597 [A] 1-23 * the whole document *
 [A]  - BALASS M ET AL, "A cyclic peptide with high affinity to [alpha]-bungarotoxin protects mice from the lethal effect of the toxin", TOXICON, (20000101), vol. 39, no. 7, doi:10.1016/S0041-0101(00)00244-0, ISSN 0041-0101, pages 1045 - 1051, XP085006042 [A] 1-23 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0041-0101(00)00244-0
International search[A]US2004031072  (LA ROSA THOMAS J [US], et al) [A] 20, 21/20 * ; paragraph [0010]; claim 2. *;
 [A]WO2007110314  (BASF PLANT SCIENCE GMBH [DE], et al) [A] 20, 21/20 * ; Table 2; claim 15. *;
 [X]  - PRADO, N. et al., "Inhibition Of The Myotoxicity Induced By Bothrops Jararacussu Venom And Isolated Phospholipases A2 By Specific Camelid Single-Domain Antibody Fragments", PLoS ONE, (20160330), vol. 11, no. 3, pages 1 - 22, XP055547660 [X] 1, 19, 21/19 * ; figure 7; abstract; page 4, first-second paragraphs; page 5, third paragraph- page 6, second paragraph; page 12, first paragraph; page 17, eighth paragraph; page 18, third-fourth paragraphs. *

DOI:   http://dx.doi.org/10.1371/journal.pone.0151363
 [X]  - LAUSTSEN, A. et al., "Recombinant Antivenoms", PhD Thesis, (20160000), pages 1 - 143, XP055606465 [X] 1-2, 3/1-2, 4/1-2, 19 * ; table 2; figures 4.2.5.B, 4.2.5.C, 4.2.5.D; page 68, fourth paragraph; page 79, first paragraph; page 83, first paragraph- page 84, first paragraph; page 85, first paragraph-page 86, second paragraph; page 87, second paragraph; page 96, first paragraph; page 107, first paragraph; page 132, first paragraph; page 134, first paragraph. *
 [PX]  - TITUS, J. et al., "Application Of Phage Display For The Development Of A Novel Inhibitor Of PLA2 Activity In Western Cottonmouth Venom", Journal of Venom Research, (20170928), vol. 8, pages 19 - 24, XP055606468 [PX] 1-2, 3/1-2, 4/1-2, 19,20, 21/19-20 * ; entire document. *
by applicantUS5709874
 US5759542
 US5840674
 US5860957
 US5900252
 US5948433
 US5965726
 US5972366
 US5983134
 US5985317
 US5985307
 US6004534
 US6010715
 US6024975
 US6039975
 US6048736
 US6060082
 US6071495
 US6120751
 US6131570
 US6139865
 US6167301
 US6174666
 US6256533
 US6253872
 US6261595
 US6267983
 US6271359
 US6274552
 US6291664
 US6316652
 US6414132
 US6794498
    - MOLENAAR, T. J. et al., "Uptake and processing of modified bacteriophage M13 in mice: implications for phage display", Virology, (20020000), vol. 293, doi:10.1006/viro.2001.1254, pages 182 - 191, XP004432835

DOI:   http://dx.doi.org/10.1006/viro.2001.1254
    - MEI et al., Blood, (20100000), vol. 116, pages 270 - 79
    - SMITH, S et al., "Bedside management considerations in the treatment of pit viper envenomation", J Emerg Nurs, (20140000), vol. 40, pages 537 - 545
    - MOWRY, J. B.SPYKER, D. A.CANTILENA, L. R., JR.BAILEY, J. E.FORD, M., "Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report", Clin Toxicol (Phila, (20120000), vol. 51, pages 949 - 1229
    - KANAAN, N.C. et al., "Wilderness Medical Society Practice Guidelines for the Treatment of Pitviper Envenomations in the United States and Canada", Wilderness Environ Med, (20150000), vol. 26, doi:10.1016/j.wem.2015.05.007, pages 472 - 487, XP029324146

DOI:   http://dx.doi.org/10.1016/j.wem.2015.05.007
    - HOLLAND, D. R. et al., "The crystal structure of a lysine 49 phospholipase A2 from the venom of the cottonmouth snake at 2.0-A resolution", J Biol Chem, (19900000), vol. 265, pages 17649 - 17656
    - FRALICK, J.CHADHA-MOHANTY, P.LI, G., Advances in Biological and Chemical Terrorism Countermeasures, CRC Press, (20080000), pages 179 - 202
    - PHILIPSON, L.ALBERTSSON, P.A.FRICK, G., "The purification and concentration of viruses by aqueous polymer phase systems", Virology, (19600000), vol. 11, doi:10.1016/0042-6822(60)90100-8, pages 553 - 571, XP023052878

DOI:   http://dx.doi.org/10.1016/0042-6822(60)90100-8
    - YU, J.SMITH, G. P., Affinity maturation of phage-displayed peptide ligands, (19960000), vol. 267, pages 3 - 27
    - PRAKASH S.S., "Phage display technology for anti-venom production", Clinical Microbiology and Infection, (20151000), vol. 13, page 4
    - RONCOLATO, E.C. et al., "Phage display as a novel promising antivenom therapy: a review", Toxicon, (20141100), vol. 93, doi:10.1016/j.toxicon.2014.11.001, pages 79 - 84, XP055504518

DOI:   http://dx.doi.org/10.1016/j.toxicon.2014.11.001
    - KOBAYASHI et al., Protein Eng, (19990000), vol. 12, no. 10, pages 879 - 884
    - BRUMMELL et al., Biochem., (19930000), vol. 32, pages 1180 - 1187
    - BURKS et al., Proc. Natl. Acad. Sci. USA, (19970000), vol. 94, pages 412 - 417
    - GIEGE R et al., Crystallogr D Biol Crystallogr, (19940000), vol. 50, pages 339 - 350
    - MCPHERSON A, Eur J Biochem, (19900000), vol. 189, pages 1 - 23
    - CHAYEN NE, Structure, (19970000), vol. 5, pages 1269 - 1274
    - MCPHERSON A, J Biol Chem, (19760000), vol. 251, pages 6300 - 6303
    - E. MEYERSW. MILLE, CABIOS, (19890000), vol. 4, pages 11 - 17
    - NEEDLEMANWUNSCH, J. Mol. Biol., (19700000), no. 48, pages 444 - 453
    - ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 10
    - ALTSCHUL et al., Nucleic Acids Res, (19970000), vol. 25, no. 17, pages 3389 - 3402
    - VAN HEEKE GSCHUSTER SM, J Biol Chem, (19890000), vol. 24, pages 5503 - 5509
    - KUTMEIER G et al., BioTechniques, (19940000), vol. 17, pages 242 - 6
    - RUETHER UMUELLER-HILL B, EMBO J, (19830000), vol. 2, pages 1791 - 1794
    - INOUYE SINOUYE M, Nuc Acids Res, (19850000), vol. 13, pages 3101 - 3109
    - LOGAN J, SHENK T, PNAS, (19840000), vol. 81, no. 12, pages 3655 - 9
    - BITTER G et al., Methods Enzymol., (19870000), vol. 153, pages 516 - 544
    - WIGLER M et al., Cell, (19770000), vol. 11, no. 1, pages 223 - 32
    - SZYBALSKA EHSZYBALSKI W, PNAS, (19620000), vol. 48, no. 12, pages 2026 - 2034
    - LOWY I et al., Cell, (19800000), vol. 22, no. 3, pages 817 - 23
    - WIGLER M et al., PNAS, (19800000), vol. 77, no. 6, pages 3567 - 70
    - MULLIGAN RC, BERG P, PNAS, (19810000), vol. 78, no. 4, pages 2072 - 31
    - WU GYWU CH, Biotherapy, (19910000), vol. 3, pages 87 - 95
    - TOLSTOSHEV P, Ann Rev Pharmacol Toxicol, (19930000), vol. 32, pages 573 - 596
    - MULLIGAN RC, Science, (19930000), vol. 260, pages 926 - 932
    - MORGAN RAANDERSON WF, Ann Rev Biochem, (19930000), vol. 62, pages 191 - 217
    - NABEL GJFELGNER PL, Trends Biotechnol, (19930000), vol. 11, no. 5, pages 211 - 5
    - SANTERRE RF et al., Gene, (19840000), vol. 30, no. 1-3, pages 147 - 56
    - ALTSCHUL, S.F.GISH, W.MILLER, W.MYERS, E.W.LIPMAN, D.J., "Basic Local Alignment Search Tool", J. Mol. Bioi., (19900000), vol. 215, doi:10.1006/jmbi.1990.9999, pages 403 - 410, XP002949123

DOI:   http://dx.doi.org/10.1006/jmbi.1990.9999
    - COLBERE-GARAPIN F et al., J Mol Biol, (19810000), vol. 150, pages 1 - 14
    - BEBBINGTON CRHENTSCHEL CCG, The use of vectors based on gene amplification for the expression of cloned genes in mammalian cells in DNA cloning, Academic Press, (19870000), vol. 3
    - CROUSE GF et al., Mol Cell Biol, (19830000), vol. 3, pages 257 - 66
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.